• Explore /
  • Poster
  • / A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application.

A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application.

Abstract Poster

Authors

Richard Royal

Richard Eldon Royal

The University of Texas MD Anderson Cancer Center, Houston, TX

Richard Eldon Royal , Luis M Vence , Tara Wray , Janice N. Cormier , Jeffrey Edwin Lee , Jeffrey E. Gershenwald , Merrick I. Ross , Jennifer Ann Wargo , Rodabe Navroze Amaria , Michael A. Davies , Adi Diab , Isabella Claudia Glitza , Wen-Jen Hwu , Sapna Pradyuman Patel , Scott Eric Woodman , Willem W Overwijk , Patrick Hwu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT00960752

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9582)

DOI

10.1200/JCO.2017.35.15_suppl.9582

Abstract #

9582

Poster Bd #

190

Abstract Disclosures

Similar Posters

First Author: Craig L. Slingluff Jr.

First Author: Nienke van Rooij

First Author: Gerald P. Linette

Poster

2011 ASCO Annual Meeting

A pilot study of endogenous heat shock protein vaccines for metastatic melanoma.

A pilot study of endogenous heat shock protein vaccines for metastatic melanoma.

First Author: J. M. Heun